ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.605
      -0.21%
      Bitcoin
      65,074.87
      -0.10%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Roquefort Therapeutics Plc (ROQ)

      7. Roquefort Therapeutics Plc (ROQ) News

      ROQ

      Roquefort Therapeutics (ROQ)

      Roquefort Therapeutics Plc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:ROQ
      DateTimeSourceHeadlineSymbolCompany
      03/13/20238:18AMAlliance NewsAlliance NewsSUMMARY: London listings with exposure to Silicon Valley BankLSE:ROQRoquefort Therapeutics Plc
      03/13/20233:30AMUK RegulatoryRoquefort Therapeutics PLC Confirmation of No Exposure to Silicon Valley BankLSE:ROQRoquefort Therapeutics Plc
      03/08/20239:29AMAlliance NewsAlliance NewsIN BRIEF: Roquefort Therapeutics announces new anti-cancer platformLSE:ROQRoquefort Therapeutics Plc
      03/08/20239:29AMAlliance NewsAlliance NewsIN BRIEF: Roquefort Therapeutics announces new anti-cancer platformLSE:ROQRoquefort Therapeutics Plc
      03/08/20232:05AMUK RegulatoryRoquefort Therapeutics PLC Creation of New Novel Family of mRNA TherapeuticsLSE:ROQRoquefort Therapeutics Plc
      03/06/202311:27AMAlliance NewsAlliance NewsIN BRIEF: Roquefort Therapeutics sets up scientific advisory boardLSE:ROQRoquefort Therapeutics Plc
      03/06/202311:27AMAlliance NewsAlliance NewsIN BRIEF: Roquefort Therapeutics sets up scientific advisory boardLSE:ROQRoquefort Therapeutics Plc
      03/06/20232:00AMUK RegulatoryRoquefort Therapeutics PLC Formation of Scientific Advisory BoardLSE:ROQRoquefort Therapeutics Plc
      03/01/20232:00AMRNS Non-RegulatoryRoquefort Therapeutics PLC Company PresentationLSE:ROQRoquefort Therapeutics Plc
      02/21/20232:00AMRNS Non-RegulatoryRoquefort Therapeutics PLC Investor PresentationLSE:ROQRoquefort Therapeutics Plc
      02/20/20239:06AMAlliance NewsAlliance NewsRoquefort signs GBP5 million deal with Randox for Midkine portfolioLSE:ROQRoquefort Therapeutics Plc
      02/20/20239:06AMAlliance NewsAlliance NewsRoquefort signs GBP5 million deal with Randox for Midkine portfolioLSE:ROQRoquefort Therapeutics Plc
      02/20/20232:00AMUK RegulatoryRoquefort Therapeutics PLC Randox Licence and Royalty AgreementLSE:ROQRoquefort Therapeutics Plc
      01/24/20239:48AMAlliance NewsAlliance NewsTRADING UPDATES: Accrol builds paper mill; Netcall interim revenue upLSE:ROQRoquefort Therapeutics Plc
      01/24/20239:48AMAlliance NewsAlliance NewsTRADING UPDATES: Accrol builds paper mill; Netcall interim revenue upLSE:ROQRoquefort Therapeutics Plc
      01/24/20232:00AMUK RegulatoryRoquefort Therapeutics PLC MDK Oncology Antibodies Demonstrate In-Vivo SafetyLSE:ROQRoquefort Therapeutics Plc
      01/18/20233:36AMUK RegulatoryRoquefort Therapeutics PLC Holding(s) in CompanyLSE:ROQRoquefort Therapeutics Plc
      01/16/20232:00AMUK RegulatoryRoquefort Therapeutics PLC Appointment of AuditorLSE:ROQRoquefort Therapeutics Plc
      01/09/20239:17AMAlliance NewsAlliance NewsRoquefort shares up as busy year-end prompts optimistic outlookLSE:ROQRoquefort Therapeutics Plc
      01/09/20239:17AMAlliance NewsAlliance NewsRoquefort shares up as busy year-end prompts optimistic outlookLSE:ROQRoquefort Therapeutics Plc
      01/09/20232:00AMUK RegulatoryRoquefort Therapeutics PLC Operations UpdateLSE:ROQRoquefort Therapeutics Plc
      12/05/20223:07AMRNS Non-RegulatoryRoquefort Therapeutics PLC Presentation of Midkine Oligonucleotide ProgramLSE:ROQRoquefort Therapeutics Plc
      12/01/20229:00AMUK RegulatoryRoquefort Therapeutics PLC Resignation of AuditorLSE:ROQRoquefort Therapeutics Plc
      10/25/20222:00AMRNS Non-RegulatoryRoquefort Therapeutics PLC Midkine Antibody Program - Festival of BiologicsLSE:ROQRoquefort Therapeutics Plc
      10/11/20228:14AMAlliance NewsAlliance NewsIN BRIEF: Roquefort Therapeutics sees positive results in cancer studyLSE:ROQRoquefort Therapeutics Plc
      10/11/20228:14AMAlliance NewsAlliance NewsIN BRIEF: Roquefort Therapeutics sees positive results in cancer studyLSE:ROQRoquefort Therapeutics Plc
      10/11/20222:00AMRNS Non-RegulatoryRoquefort Therapeutics PLC ROQ Presents Study Results at the ESGCT ConferenceLSE:ROQRoquefort Therapeutics Plc
      09/28/20222:02AMUK RegulatoryRoquefort Therapeutics PLC Director/PDMR ShareholdingLSE:ROQRoquefort Therapeutics Plc
      09/26/20229:30AMUK RegulatoryRoquefort Therapeutics PLC Director/PDMR ShareholdingLSE:ROQRoquefort Therapeutics Plc
      09/23/20224:28AMAlliance NewsAlliance NewsRoquefort Therapeutics losses widen but boasts strong cash balanceLSE:ROQRoquefort Therapeutics Plc
       Showing the most relevant articles for your search:LSE:ROQ